ADK — Diagnos Cashflow Statement
0.000.00%
Last trade - 00:00- CA$46.29m
- CA$45.76m
- CA$0.07m
Annual cashflow statement for Diagnos, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | C2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.61 | -2.48 | -3.12 | -4.29 | -4.56 |
| Depreciation | |||||
| Non-Cash Items | 0.457 | 0.29 | 0.433 | 0.527 | 0.546 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.008 | 0.205 | 0.416 | -0.006 | 0.126 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.04 | -1.88 | -2.15 | -3.64 | -3.75 |
| Capital Expenditures | -0.031 | -0.024 | -0.011 | -0.014 | -0.011 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.535 | 0.499 | -0.003 | -3.1 | 1.57 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.504 | 0.475 | -0.014 | -3.11 | 1.56 |
| Financing Cash Flow Items | -0.023 | -0.118 | -0.263 | -0.285 | -0.248 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.6 | 1.28 | 2.08 | 6.62 | 2.41 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.062 | -0.124 | -0.078 | -0.13 | 0.221 |